We showed that ELF3 exhibits mutually exclusive patterns of expression with CTNNB1/ β-catenin across colorectal tumour panels and that ELF3 is an antagonist of Wnt/β-catenin and RAS signalling-induced EMT. The gene discussed is ELF3; the disease is colorectal neoplasm.